A New Lead Identification Strategy: Screening an sp 3 ‐rich and Lead‐like Compound Library Composed of 7‐Azanorbornane Derivatives-Reference-Cited by-同舟云学术

A New Lead Identification Strategy: Screening an sp 3 ‐rich and Lead‐like Compound Library Composed of 7‐Azanorbornane Derivatives

Published:2019-09-20 Issue:21 Volume:14 Page:1840-1848
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Karaki Fumika¹²^ORCID,Umemoto Sho¹,Ashizawa Karin¹³,Oki Tomoya¹,Sato Noriko⁴,Ogino Takumi¹³,Ishibashi Naoto¹³,Someya Ryoto¹³,Miyano Kanako³^ORCID,Hirayama Shigeto¹²^ORCID,Uezono Yasuhito³⁵⁶⁷^ORCID,Fujii Hideaki¹²^ORCID

Affiliation:

1. Laboratory of Medicinal Chemistry School of Pharmacy Kitasato University 5-9-1, Shirokane, Minato-ku Tokyo 108-8641 Japan

2. Medicinal Research Laboratories School of Pharmacy Kitasato University 5-9-1, Shirokane, Minato-ku Tokyo 108-8641 Japan

3. Division of Cancer Pathophysiology National Cancer Center Research Institute 5-1-1 Tsukiji, Chuo-ku Tokyo 104-0045 Japan

4. Analytical Unit for Organic Chemistry Kitasato University 5-9-1, Shirokane, Minato-ku Tokyo 108-8641 Japan

5. Division of Supportive Care Research Exploratory Oncology Research & Clinical Trial Center National Cancer Center 5-1-1 Tsukiji, Chuo-ku Tokyo 104-0045 Japan

6. Innovation Center for Supportive, Palliative and Psychosocial Care National Cancer Center Hospital 5-1-1 Tsukiji, Chuo-ku Tokyo 104-0045 Japan

7. Department of Comprehensive Oncology Graduate School of Biomedical Sciences Nagasaki University 1-12-4 Sakamoto Nagasaki 852-8523 Japan

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.201900398

Reference50 articles.

1. Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success

2. Escape from Flatland 2: complexity and promiscuity

3. Identification of Selective Acyl Sulfonamide–Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (NaV) 1.7 with Potent Analgesic Activity